https://media-us.eisai.com/ Eisai Newsroom https://media-us.eisai.com/2023-08-17-EISAI-INC-S-U-S-HEADQUARTERS-EARNS-THREE-KEY-BUILDING-CERTIFICATIONS Thu, 17 Aug 2023 08:00:00 -0400 https://media-us.eisai.com/2023-08-17-EISAI-INC-S-U-S-HEADQUARTERS-EARNS-THREE-KEY-BUILDING-CERTIFICATIONS https://media-us.eisai.com/EISAI-TO-DIVEST-RIGHTS-FOR-ANTI-EPILEPTIC-DRUG-FYCOMPA-R-perampanel-CIII-IN-UNITED-STATES-TO-CATALYST-PHARMACEUTICALS Mon, 19 Dec 2022 18:00:00 -0500 https://media-us.eisai.com/EISAI-TO-DIVEST-RIGHTS-FOR-ANTI-EPILEPTIC-DRUG-FYCOMPA-R-perampanel-CIII-IN-UNITED-STATES-TO-CATALYST-PHARMACEUTICALS https://media-us.eisai.com/2022-08-18-Eisai-Inc-Reinforces-Commitment-to-Collaboration-and-Innovation-to-Support-Patients-and-Communities-Through-New-U-S-Headquarters Thu, 18 Aug 2022 10:05:00 -0400 https://media-us.eisai.com/2022-08-18-Eisai-Inc-Reinforces-Commitment-to-Collaboration-and-Innovation-to-Support-Patients-and-Communities-Through-New-U-S-Headquarters https://media-us.eisai.com/2022-07-27-Eisai-Announces-Key-Executive-Appointment-for-Alzheimers-Disease-Leadership Wed, 27 Jul 2022 08:00:00 -0400 https://media-us.eisai.com/2022-07-27-Eisai-Announces-Key-Executive-Appointment-for-Alzheimers-Disease-Leadership https://media-us.eisai.com/2022-01-24-EISAI-INC-ANNOUNCES-THE-APPOINTMENT-OF-TRICIA-BROOKS-AS-VICE-PRESIDENT-HEAD-OF-OFFICE,-GOVERNMENT-AFFAIRS-AND-POLICY Mon, 24 Jan 2022 08:05:00 -0500 https://media-us.eisai.com/2022-01-24-EISAI-INC-ANNOUNCES-THE-APPOINTMENT-OF-TRICIA-BROOKS-AS-VICE-PRESIDENT-HEAD-OF-OFFICE,-GOVERNMENT-AFFAIRS-AND-POLICY https://media-us.eisai.com/2021-08-30-Eisai-Announces-New-Executive-Leadership-Team-at-H3-Biomedicine Mon, 30 Aug 2021 07:55:00 -0400 https://media-us.eisai.com/2021-08-30-Eisai-Announces-New-Executive-Leadership-Team-at-H3-Biomedicine https://media-us.eisai.com/2021-08-05-Eisai-Inc-Announces-the-Appointment-of-Dr-Janna-Hutz-as-President-of-the-Eisai-Center-for-Genetics-Guided-Dementia-Discovery Thu, 05 Aug 2021 07:55:00 -0400 https://media-us.eisai.com/2021-08-05-Eisai-Inc-Announces-the-Appointment-of-Dr-Janna-Hutz-as-President-of-the-Eisai-Center-for-Genetics-Guided-Dementia-Discovery https://media-us.eisai.com/2021-06-28-Eisai-Inc-Announces-the-Appointment-of-Dr-Andree-Amelsberg-as-Vice-President,-U-S-Medical-Affairs,-Oncology-Business-Group Mon, 28 Jun 2021 07:55:00 -0400 https://media-us.eisai.com/2021-06-28-Eisai-Inc-Announces-the-Appointment-of-Dr-Andree-Amelsberg-as-Vice-President,-U-S-Medical-Affairs,-Oncology-Business-Group https://media-us.eisai.com/An-Animation-Featuring-Lymphatic-Filariasis-Elimination-Activities-Receives-Animation-Award-at-International-Society-for-Neglected-Tropical-Diseases-Festival-2021 Sun, 11 Apr 2021 15:08:00 -0400 https://media-us.eisai.com/An-Animation-Featuring-Lymphatic-Filariasis-Elimination-Activities-Receives-Animation-Award-at-International-Society-for-Neglected-Tropical-Diseases-Festival-2021 https://media-us.eisai.com/2021-02-02-Eisai-and-BioLabs-Partner-to-Create-the-Eisai-Innovation-Center-BioLabs Companies launch neurology-focused incubator at Eisai's G2D2 facility in Cambridge, Mass. Tue, 02 Feb 2021 14:39:00 -0500 https://media-us.eisai.com/2021-02-02-Eisai-and-BioLabs-Partner-to-Create-the-Eisai-Innovation-Center-BioLabs https://media-us.eisai.com/Eisai-Listed-As-A-Global-100-Most-Sustainable-Corporation-For-The-Fifth-Time HIGHEST RANKED GLOBAL PHARMACEUTICAL COMPANY Tue, 26 Jan 2021 08:48:00 -0500 https://media-us.eisai.com/Eisai-Listed-As-A-Global-100-Most-Sustainable-Corporation-For-The-Fifth-Time https://media-us.eisai.com/2021-01-20-Dr-Richard-Woodman-Appointed-Chief-Clinical-Officer-of-the-Oncology-Business-Group-at-Eisai-Inc Wed, 20 Jan 2021 07:55:00 -0500 https://media-us.eisai.com/2021-01-20-Dr-Richard-Woodman-Appointed-Chief-Clinical-Officer-of-the-Oncology-Business-Group-at-Eisai-Inc https://media-us.eisai.com/GLOBAL-COALITION-FOR-ADAPTIVE-RESEARCH-AMGEN-AND-EISAI-ANNOUNCE-FIRST-PATIENT-ENROLLED-IN-INTERNATIONAL-COVID-19-TRIAL AMGEN AND EISAI TO PARTICIPATE IN THE IMMUNE MODULATION DOMAIN OF REMAP-COVID, AN ADAPTIVE CLINICAL TRIAL TO TEST INTERVENTIONS FOR PATIENTS HOSPITALIZED WITH COVID-19 Tue, 27 Oct 2020 10:03:00 -0400 https://media-us.eisai.com/GLOBAL-COALITION-FOR-ADAPTIVE-RESEARCH-AMGEN-AND-EISAI-ANNOUNCE-FIRST-PATIENT-ENROLLED-IN-INTERNATIONAL-COVID-19-TRIAL https://media-us.eisai.com/2020-08-11-Eisai-Pharmaceuticals-to-Make-the-ON3-Next-Generation-Life-Science-and-Lifestyle-Campus-its-U-S-Headquarters - Focusing in Scientific Innovation and Collaboration in Oncology, Alzheimer's disease and other Neurological Disorders Tue, 11 Aug 2020 09:05:00 -0400 https://media-us.eisai.com/2020-08-11-Eisai-Pharmaceuticals-to-Make-the-ON3-Next-Generation-Life-Science-and-Lifestyle-Campus-its-U-S-Headquarters https://media-us.eisai.com/2020-02-03-Eisai-Inc-Expands-Leadership-Team-in-the-US-with-the-Appointment-of-Two-Key-Leaders Executive Appointments: Mon, 03 Feb 2020 07:58:00 -0500 https://media-us.eisai.com/2020-02-03-Eisai-Inc-Expands-Leadership-Team-in-the-US-with-the-Appointment-of-Two-Key-Leaders https://media-us.eisai.com/Eisai-Rated-A-the-highest-rating-in-the-CDP-Climate-Change-Report-2019 Wed, 22 Jan 2020 08:07:00 -0500 https://media-us.eisai.com/Eisai-Rated-A-the-highest-rating-in-the-CDP-Climate-Change-Report-2019 https://media-us.eisai.com/2019-08-26-Priya-Chaturvedi-Ph-D-Appointed-Vice-President-of-Global-Clinical-Quality-Assurance-at-Eisai-Inc Mon, 26 Aug 2019 07:55:00 -0400 https://media-us.eisai.com/2019-08-26-Priya-Chaturvedi-Ph-D-Appointed-Vice-President-of-Global-Clinical-Quality-Assurance-at-Eisai-Inc https://media-us.eisai.com/2019-06-04-Patrick-Coyle-Appointed-Vice-President-and-Chief-Financial-Officer-of-Eisai-Inc Tue, 04 Jun 2019 08:00:00 -0400 https://media-us.eisai.com/2019-06-04-Patrick-Coyle-Appointed-Vice-President-and-Chief-Financial-Officer-of-Eisai-Inc https://media-us.eisai.com/2019-05-29-Adriana-Herrera-Appointed-Senior-Vice-President-Americas-Commercial-Oncology-at-Eisai-Inc Wed, 29 May 2019 08:00:00 -0400 https://media-us.eisai.com/2019-05-29-Adriana-Herrera-Appointed-Senior-Vice-President-Americas-Commercial-Oncology-at-Eisai-Inc https://media-us.eisai.com/2019-05-20-Eisai-Inc-Announces-the-Appointment-of-Dr-Luca-Dezzani-as-Vice-President-U-S-Medical-Affairs-Oncology-Business-Group Mon, 20 May 2019 08:00:00 -0400 https://media-us.eisai.com/2019-05-20-Eisai-Inc-Announces-the-Appointment-of-Dr-Luca-Dezzani-as-Vice-President-U-S-Medical-Affairs-Oncology-Business-Group https://media-us.eisai.com/2019-05-02-Eisai-Inc-Deepens-Its-Commitment-to-Alzheimers-Disease-with-Key-Executive-Appointments Dr. Harald Hampel hired as Vice President, Global Medical Affairs, Alzheimer's Disease; Thu, 02 May 2019 15:58:00 -0400 https://media-us.eisai.com/2019-05-02-Eisai-Inc-Deepens-Its-Commitment-to-Alzheimers-Disease-with-Key-Executive-Appointments https://media-us.eisai.com/2018-08-27-Stephen-Davies-Appointed-Vice-President-Eisai-Strategic-Information-Systems-at-Eisai-Inc Mon, 27 Aug 2018 08:00:00 -0400 https://media-us.eisai.com/2018-08-27-Stephen-Davies-Appointed-Vice-President-Eisai-Strategic-Information-Systems-at-Eisai-Inc https://media-us.eisai.com/2018-06-12-Eisai-Inc-to-Launch-Center-for-Genetics-Guided-Dementia-Discovery-in-Cambridge-Massachusetts - Will accelerate discovery of next-generation immunodementia therapeutics that go beyond A-beta and tau by targeting immune mechanisms identified by human genetics Tue, 12 Jun 2018 16:30:00 -0400 https://media-us.eisai.com/2018-06-12-Eisai-Inc-to-Launch-Center-for-Genetics-Guided-Dementia-Discovery-in-Cambridge-Massachusetts https://media-us.eisai.com/2018-06-11-Lihua-Yu-Ph-D-Appointed-President-Chief-Data-Sciences-Officer-H3-Biomedicine Mon, 11 Jun 2018 14:00:00 -0400 https://media-us.eisai.com/2018-06-11-Lihua-Yu-Ph-D-Appointed-President-Chief-Data-Sciences-Officer-H3-Biomedicine https://media-us.eisai.com/2017-10-03-Eisai-Inc-and-Grupo-Biotoscana-Sign-Exclusive-Licensing-Agreement-for-the-Commercialization-of-Eisais-Oncology-and-Neurology-Products-throughout-Latin-America Tue, 03 Oct 2017 08:00:00 -0400 https://media-us.eisai.com/2017-10-03-Eisai-Inc-and-Grupo-Biotoscana-Sign-Exclusive-Licensing-Agreement-for-the-Commercialization-of-Eisais-Oncology-and-Neurology-Products-throughout-Latin-America